BETH ISRAEL DEACONESS MEDICAL CENTER
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination is a funding opportunity from BETH ISRAEL DEACONESS MEDICAL CENTER, up to 1500997, closing April 30, 2028.
Apr 30, 2028
(639d left)Overview
SUMMARY The goal of this P01 program is to define mechanisms of efficacy of broadly neutralizing antibodies (bNAbs) and therapeutic vaccines for HIV-1 in a highly collaborative and multifaceted research program. Our overall hypothesis is that immunologic strategies for HIV-1 cure delay viral rebound both by targeting…